What does MOVE KINESITHERAPIE do?

MOVE KINESITHERAPIE is a healthcare practice in Gent. Private Limited, started on 26 March 2019, 1 establishment.

What is the address of MOVE KINESITHERAPIE?

The registered office of MOVE KINESITHERAPIE is located at Loofblommestraat 41, 9051 Gent.

Is MOVE KINESITHERAPIE still active?

Yes. According to the CBE (31 October 2026) MOVE KINESITHERAPIE is active, legal situation “Normale toestand”, started on 26 March 2019.

Is MOVE KINESITHERAPIE registered on Peppol?

Yes, MOVE KINESITHERAPIE is registered on the Peppol network with ID 0208:0723612377.

What is the enterprise number of MOVE KINESITHERAPIE?

The enterprise number of MOVE KINESITHERAPIE is BE0723612377.

When was MOVE KINESITHERAPIE founded?

MOVE KINESITHERAPIE was founded on 26 March 2019.

Who are the directors of MOVE KINESITHERAPIE?

According to the 2025 annual accounts, the directors of MOVE KINESITHERAPIE are: RUBEN Ghyselinck.

Is MOVE KINESITHERAPIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 March 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MOVE KINESITHERAPIE make in 2025?

MOVE KINESITHERAPIE posted a profit after taxes of € 74,250 in financial year 2025.

What is the revenue of MOVE KINESITHERAPIE?

As a small company, MOVE KINESITHERAPIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 125,392.

Does MOVE KINESITHERAPIE have a website?

Yes, MOVE KINESITHERAPIE has a website at movekinesitherapie.be.

MOVE KINESITHERAPIE (Private Limited) - Gent

Dossier MOVE KINESITHERAPIE, printed on 31 October 2026 from databakkes.be/en/0723612377/move-kinesitherapie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MOVE KINESITHERAPIE from Gent, company number BE0723612377, closed financial year 2025 with a result of € 74,250 after tax. For that financial year MOVE KINESITHERAPIE recorded a gross margin of € 125,392 and equity of € 109,840. Compared with financial year 2024, the result moved from € 11,355 to € 74,250. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 109,840

▲ 62% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 74,250

▲ € 62,895 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 116,012

▲ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 32,263 paid out

43 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 12,868

▼ 56% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 51,611

▼ 20% vs 2024

€ 4,484 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 18,071

▲ 105% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 27,086

▲ € 21,279 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 15,472 Gross margin 2022: € 15,472 First fiscal year in the series	€ 46,064 Gross margin 2023: € 46,064 ▲ 198% vs 2022 (€ 15,472) Favourable step	€ 49,829 Gross margin 2024: € 49,829 ▲ 8% vs 2023 (€ 46,064) Favourable step	€ 125,392 Gross margin 2025: € 125,392 ▲ 152% vs 2024 (€ 49,829) Favourable step	▲ 152%
Profit after taxes	€ -5,105 Profit after taxes 2022: € -5,105 First fiscal year in the series	€ 15,822 Profit after taxes 2023: € 15,822 ▲ € 20,927 vs 2022 (€ -5,105) Favourable step	€ 11,355 Profit after taxes 2024: € 11,355 ▼ 28% vs 2023 (€ 15,822) Unfavourable step	€ 74,250 Profit after taxes 2025: € 74,250 ▲ € 62,895 vs 2024 (€ 11,355) Favourable step	▲ € 62,895
Equity	€ 86,209 Equity 2022: € 86,209 First fiscal year in the series	€ 102,031 Equity 2023: € 102,031 ▲ 18% vs 2022 (€ 86,209) Favourable step	€ 67,852 Equity 2024: € 67,852 ▼ 33% vs 2023 (€ 102,031) Unfavourable step	€ 109,840 Equity 2025: € 109,840 ▲ 62% vs 2024 (€ 67,852) Favourable step	▲ 62%
Total debts	€ 110,130 Total debts 2022: € 110,130 First fiscal year in the series	€ 101,221 Total debts 2023: € 101,221 ▼ 8% vs 2022 (€ 110,130) Favourable step	€ 151,525 Total debts 2024: € 151,525 ▲ 50% vs 2023 (€ 101,221) Unfavourable step	€ 140,324 Total debts 2025: € 140,324 ▼ 7% vs 2024 (€ 151,525) Favourable step	▼ 7%
Cash	€ 22,798 Cash 2022: € 22,798 First fiscal year in the series	€ 64,042 Cash 2023: € 64,042 ▲ 181% vs 2022 (€ 22,798) Favourable step	€ 85,883 Cash 2024: € 85,883 ▲ 34% vs 2023 (€ 64,042) Favourable step	€ 116,012 Cash 2025: € 116,012 ▲ 35% vs 2024 (€ 85,883) Favourable step	▲ 35%
Retained profit	€ 66,209 Retained profit 2022: € 66,209 First fiscal year in the series	€ 82,031 Retained profit 2023: € 82,031 ▲ 24% vs 2022 (€ 66,209) Favourable step	€ 47,852 Retained profit 2024: € 47,852 ▼ 42% vs 2023 (€ 82,031) Unfavourable step	€ 89,840 Retained profit 2025: € 89,840 ▲ 88% vs 2024 (€ 47,852) Favourable step	▲ 88%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 45,534 Dividend 2024: € 45,534 Unchanged (€ 0) Unchanged	€ 32,263 Dividend 2025: € 32,263 ▼ 29% vs 2024 (€ 45,534) Unchanged	▼ 29%
Bank debt	€ 87,044 Bank debt 2022: € 87,044 First fiscal year in the series	€ 77,079 Bank debt 2023: € 77,079 ▼ 11% vs 2022 (€ 87,044) Favourable step	€ 64,532 Bank debt 2024: € 64,532 ▼ 16% vs 2023 (€ 77,079) Favourable step	€ 51,611 Bank debt 2025: € 51,611 ▼ 20% vs 2024 (€ 64,532) Favourable step	▼ 20%
Balance sheet total	€ 196,339 Balance sheet total 2022: € 196,339 First fiscal year in the series	€ 203,252 Balance sheet total 2023: € 203,252 ▲ 4% vs 2022 (€ 196,339) Unchanged	€ 219,377 Balance sheet total 2024: € 219,377 ▲ 8% vs 2023 (€ 203,252) Unchanged	€ 250,164 Balance sheet total 2025: € 250,164 ▲ 14% vs 2024 (€ 219,377) Unchanged	▲ 14%

Key figures of MOVE KINESITHERAPIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MOVE KINESITHERAPIE?

What happened at MOVE KINESITHERAPIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 74,250 (▲ € 62,895 vs 2024). filed late Source: NBB ↗
Mar 26, 2019 New establishment in Gent. KBO
Mar 26, 2019 Start of the company according to the CBE. KBO
2019 RUBEN Ghyselinck became a director. NBB

In short

From € 5,105 loss in 2022 to € 74,250 profit in 2025.

Paid € 25,375 in corporate taxes since 2022.

Best year ever: 2025, with € 74,250 profit.

Paid out € 77,796 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

RUBEN Ghyselinck

MOVE KINESITHERAPIE

Behind MOVE KINESITHERAPIE is RUBEN Ghyselinck.

Directors

According to the 2025 annual accounts

RUBEN Ghyselinck

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Loofblommestraat 41

9051 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MOVE 2.0.

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS movekinesitherapie.be

Canonical: https://movekinesitherapie.be/home/

Technologies

Cookie ConsentGoogle AnalyticsGoogle FontsLiteSpeedPHPWPMLWooCommerceWordPressYoast SEOjQuery

Hosting & Email

Email provider

Self-hosted

Hosting

DUOCAST-AS, NL

Website info

HTTPS Ja

Languages NL

Features

Webshop Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0723.612.377

VAT number

BE 0723.612.377

Registered office

Loofblommestraat 41, 9051 Gent

Names & denominations

MOVE KINESITHERAPIE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 March 2019

Peppol

Active · Active since 7 Mar 2025

Contact

movekinesitherapie.be

Activities · NACE

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

Overige vormen van onderwijs

Exploitatie van sportaccommodaties

View on CBE Public ↗ Annual accounts (NBB) ↗

MOVE KINESITHERAPIE

Financials

What happened to MOVE KINESITHERAPIE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions